BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33616470)

  • 1. A novel RUNX1 exon 3 - 7 deletion causing a familial platelet disorder.
    Almazni I; Chudakou P; Dawson-Meadows A; Downes K; Freson K; Mason J; Page P; Reay K; Myers B; Morgan NV;
    Platelets; 2022 Feb; 33(2):320-323. PubMed ID: 33616470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
    Schlegelberger B; Heller PG
    Semin Hematol; 2017 Apr; 54(2):75-80. PubMed ID: 28637620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
    Latger-Cannard V; Philippe C; Bouquet A; Baccini V; Alessi MC; Ankri A; Bauters A; Bayart S; Cornillet-Lefebvre P; Daliphard S; Mozziconacci MJ; Renneville A; Ballerini P; Leverger G; Sobol H; Jonveaux P; Preudhomme C; Nurden P; Lecompte T; Favier R
    Orphanet J Rare Dis; 2016 Apr; 11():49. PubMed ID: 27112265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies.
    Kirito K; Sakoe K; Shinoda D; Takiyama Y; Kaushansky K; Komatsu N
    Haematologica; 2008 Jan; 93(1):155-6. PubMed ID: 18166807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Marrow Morphology Associated With Germline
    Chisholm KM; Denton C; Keel S; Geddis AE; Xu M; Appel BE; Cantor AB; Fleming MD; Shimamura A
    Pediatr Dev Pathol; 2019; 22(4):315-328. PubMed ID: 30600763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid neoplasms with germ line RUNX1 mutation.
    Hayashi Y; Harada Y; Huang G; Harada H
    Int J Hematol; 2017 Aug; 106(2):183-188. PubMed ID: 28534116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy.
    Yu K; Deuitch N; Merguerian M; Cunningham L; Davis J; Bresciani E; Diemer J; Andrews E; Young A; Donovan F; Sood R; Craft K; Chong S; Chandrasekharappa S; Mullikin J; Liu PP
    Blood Adv; 2024 Jan; 8(2):497-511. PubMed ID: 38019014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia.
    Cavalcante de Andrade Silva M; Krepischi ACV; Kulikowski LD; Zanardo EA; Nardinelli L; Leal AM; Costa SS; Muto NH; Rocha V; Velloso EDRP
    Cancer Genet; 2018 Apr; 222-223():32-37. PubMed ID: 29666006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial platelet disorder with predisposition to myeloid leukemia (FPD/AML): a case report and literature review].
    Zhang RR; Chen XJ; Ren YY; Yang WY; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):308-312. PubMed ID: 33979975
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial platelet disorder due to germline exonic deletions in
    Engvall M; Karlsson Y; Kuchinskaya E; Jörnegren Å; Mathot L; Pandzic T; Palle J; Ljungström V; Cavelier L; Hellström Lindberg E; Cammenga J; Baliakas P
    Leuk Lymphoma; 2022 Oct; 63(10):2311-2320. PubMed ID: 35533071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant.
    Lamolda M; Montes R; Simón I; Perales S; Martínez-Navajas G; Lopez-Onieva L; Ríos-Pelegrina R; Del Moral RG; Griñan-Lison C; Marchal JA; Lozano ML; Ramos-Mejia V; Rivera J; Bastida JM; Real PJ
    Stem Cell Res; 2019 Dec; 41():101603. PubMed ID: 31698193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations.
    Toratani K; Watanabe M; Kanda J; Oka T; Hyuga M; Arai Y; Iwasaki M; Sakurada M; Nannya Y; Ogawa S; Yamada T; Takaori-Kondo A
    Int J Hematol; 2023 Sep; 118(3):400-405. PubMed ID: 36897502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies.
    Duarte BKL; Yamaguti-Hayakawa GG; Medina SS; Siqueira LH; Snetsinger B; Costa FF; Rauh MJ; Ozelo MC
    Br J Haematol; 2019 Sep; 186(5):724-734. PubMed ID: 31124578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects.
    Connelly JP; Kwon EM; Gao Y; Trivedi NS; Elkahloun AG; Horwitz MS; Cheng L; Liu PP
    Blood; 2014 Sep; 124(12):1926-30. PubMed ID: 25114263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of clinical and genetic features of patients with inherited platelet disorder with suspected predisposition to hematological malignancies: a nationwide survey in Japan.
    Yoshimi A; Toya T; Nannya Y; Takaoka K; Kirito K; Ito E; Nakajima H; Hayashi Y; Takahashi T; Moriya-Saito A; Suzuki K; Harada H; Komatsu N; Usuki K; Ichikawa M; Kurokawa M
    Ann Oncol; 2016 May; 27(5):887-95. PubMed ID: 26884589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene of the issue: RUNX1 mutations and inherited bleeding.
    Morgan NV; Daly ME
    Platelets; 2017 Mar; 28(2):208-210. PubMed ID: 28277065
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.
    Iizuka H; Kagoya Y; Kataoka K; Yoshimi A; Miyauchi M; Taoka K; Kumano K; Yamamoto T; Hotta A; Arai S; Kurokawa M
    Exp Hematol; 2015 Oct; 43(10):849-57. PubMed ID: 26021490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0.
    Manchev VT; Bouzid H; Antony-Debré I; Leite B; Meurice G; Droin N; Prebet T; Costello RT; Vainchenker W; Plo I; Diop M; Macintyre E; Asnafi V; Favier R; Baccini V; Raslova H
    J Cell Mol Med; 2017 Jun; 21(6):1237-1242. PubMed ID: 27997762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.
    Preudhomme C; Renneville A; Bourdon V; Philippe N; Roche-Lestienne C; Boissel N; Dhedin N; André JM; Cornillet-Lefebvre P; Baruchel A; Mozziconacci MJ; Sobol H
    Blood; 2009 May; 113(22):5583-7. PubMed ID: 19357396
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.